Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial. | |
Hecht, J. Randolph; Bang, Yung-Jue; Qin, Shukui; Chung, Hyun-Chul; Xu, Jian-Ming; Park, Joon Oh; Jeziorski, Krzysztof; Shparyk, Yaroslav; Hoff, Paulo M.; Sobrero, Alberto F. | |
2013 | |
卷号 | 31 |
期号 | 18 |
会议录 | JOURNAL OF CLINICAL ONCOLOGY |
语种 | 英语 |
URL标识 | 查看原文 |
ISSN号 | 0732-183X |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4892292 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Hecht, J. Randolph,Bang, Yung-Jue,Qin, Shukui,et al. Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial.[C]. 见:. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论